121 related articles for article (PubMed ID: 7839426)
1. Importance of concomitant viral infection during late acute liver allograft rejection.
Cakaloglu Y; Devlin J; O'Grady J; Sutherland S; Portmann BC; Heaton N; Tan KC; Williams R
Transplantation; 1995 Jan; 59(1):40-5. PubMed ID: 7839426
[TBL] [Abstract][Full Text] [Related]
2. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.
Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Cox K; Krams SM
Transplantation; 1995 Feb; 59(4):519-24. PubMed ID: 7878757
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of cytomegalovirus hepatitis in liver transplant patients.
Bronsther O; Makowka L; Jaffe R; Demetris AJ; Breinig MK; Ho M; Esquivel CO; Gordon RD; Iwatsuki S; Tzakis A
J Med Virol; 1988 Apr; 24(4):423-34. PubMed ID: 2835433
[TBL] [Abstract][Full Text] [Related]
4. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
5. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
6. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
7. [Early postoperative infections after liver transplantation--pathogen spectrum and risk factors].
Götzinger P; Sautner T; Wamser P; Gebhard B; Barlan M; Steininger R; Függer R; Mühlbacher F
Wien Klin Wochenschr; 1996 Dec; 108(24):795-801. PubMed ID: 9092210
[TBL] [Abstract][Full Text] [Related]
8. Viral infections in renal transplant recipients: an evolutionary problem.
Charpentier B
Adv Nephrol Necker Hosp; 1986; 15():353-78. PubMed ID: 3006452
[No Abstract] [Full Text] [Related]
9. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
Peleg AY; Husain S; Kwak EJ; Silveira FP; Ndirangu M; Tran J; Shutt KA; Shapiro R; Thai N; Abu-Elmagd K; McCurry KR; Marcos A; Paterson DL
Clin Infect Dis; 2007 Jan; 44(2):204-12. PubMed ID: 17173218
[TBL] [Abstract][Full Text] [Related]
10. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
[TBL] [Abstract][Full Text] [Related]
11. Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol.
Birkeland SA; Andersen HK; Hamilton-Dutoit SJ
Transplantation; 1999 May; 67(9):1209-14. PubMed ID: 10342310
[TBL] [Abstract][Full Text] [Related]
12. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
13. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
[TBL] [Abstract][Full Text] [Related]
14. [Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy].
Bernal I; Domènech E; García-Planella E; Cabré E; Gassull MA
Gastroenterol Hepatol; 2003 Jan; 26(1):19-22. PubMed ID: 12525323
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
[TBL] [Abstract][Full Text] [Related]
16. Viral infections in acute graft-versus-host disease: a review of diagnostic and therapeutic approaches.
Tong LX; Worswick SD
J Am Acad Dermatol; 2015 Apr; 72(4):696-702. PubMed ID: 25582535
[TBL] [Abstract][Full Text] [Related]
17. Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients.
Verma A; Palaniswamy K; Cremonini G; Heaton N; Dhawan A
Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28134467
[TBL] [Abstract][Full Text] [Related]
18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
19. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
Tryphonopoulos P; Weppler D; Morris MI; Russo C; Nishida S; Levi DM; Moon J; Tekin A; Selvaggi G; Island E; Arosemena L; Ruiz P; Tzakis AG
Transplantation; 2011 Nov; 92(9):1051-7. PubMed ID: 21876474
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.
Helfrich M; Dorschner P; Thomas K; Stosor V; Ison MG
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
